? The authors propose a wearable bracelet to kerb the spread of Coronavirus (COVID-19). have become popular in many applications. These are electronic devices, worn on the body, comprising detectors which log info on physiological guidelines and user connection with the environment. In 2017, in Vernakalant (RSD1235) the U.S. only, 17% of adults used a wearable device.1 With advances in technology, there is now an opportunity to benefit from data collected from wearable devices at a population level. The Internet of Items (IoT) is definitely a grid of interconnected products, machines, objects or people with unique identifiers (UIDs) that transfer data over a network. IoT can facilitate extrapolation of associations, patterns and styles within extremely large data units to provide near real-time insights to ensure a data-driven, informed response to the pandemic. Such wearables can offer a centralised remedy for simultaneously tracking Coronavirus (COVID-19) data and digital diagnostics at both individual and population levels. In this instance, we propose a customized biometric bracelet with a wireless communication circuit and a subscriber identity module that has three built-in features: (1) an infrared thermometer, (2) a worldwide positioning program (Gps navigation) and (3) a radio-frequency recognition (RFID) with an UID quantity. The bracelet would utilize the IoT to transfer data more than a network for an interactive web-based dashboard that paths COVID-19 in real-time. Putting on the bracelet will be suggested within a predefined geographic region. Big data analytics could after that give a centralised bird’s attention perspective of growing developments and patterns to improve response and containment. Infrared thermometer for early testing on a human population level The necessity for early testing at a human population level continues to be one of many challenges from the pandemic. With fever becoming one of the most common showing symptoms (43.8% upon medical center admission, 88.7% during hospitalisation),2 many countries possess used devices such as for example temperature guns to measure fever like a hurdle of entry into open public places. Still, monitoring fever needs visitors to self-report and positively look for health care mainly, leaving numerous instances unreported. As fever objectively is simple to measure, a biometric bracelet could measure fluctuations in temp using a infrared sensor continuously. Thus, if a fever can be got with a person, they may be approached with a doctor instantly, examined or screened for SARS-CoV-2, as required. If a person examined positive for SARS-CoV-2, the database could automatically trace back anyone they had come in contact within the past 14 days using a GPS CANPml feature (described in the following paragraphs). Potential carriers could then self-isolate, be tested and treated as required. GPS for contact tracing of infection chains Contact tracing plays an important role in the control of emerging infectious diseases and has been used successfully to mitigate the spread of numerous past outbreaks including smallpox and severe acute respiratory syndrome (SARS).3 In this instance, the biometric bracelet’s GPS feature would continuously track movements of individuals within a geographical area and Vernakalant (RSD1235) communicate back to the Vernakalant (RSD1235) COVID-19 database platform saving input on the population whereabouts at each time Vernakalant (RSD1235) point. The database could then use advanced data analytics to extract a list of other people that were within a predefined distance of an infected individual at a certain day and time. The bracelet could also send an alert using a beeping sound or vibration to people at risk of having been in contact with a confirmed positive case. RFID for tracking immunity status To date, only incomplete information is available on the host innate immune status of SARS-CoV-2Cinfected patients. Based on Vernakalant (RSD1235) published research on other coronaviruses, some form of active immunity can be expected.4 The global race to develop and approve accurate, widespread antibody tests for SARS-CoV-2 is well on its way. Although several practical questions remain due to an incomplete understanding of how the virus triggers immune recognition and neutralisation.5 As more people are infected, most are likely to generate an immune response. This may lead to a need for a community-wide immunity status classification, for example: (1) previously infected, now immune, noninfectious, ( 2 ) presently ( and contaminated?ve, susceptible to infection still. Over time, we may see different sets of limitations/privileges for those who have.